Login / Signup

Distinguishing recurrence and new primary tumor as well as the origin of neck metastases in head and neck cancer clinical trials by targeted DNA sequencing.

Jacob Kinggaard Lilja-FischerMette SaksøMagnus StougaardTorben SteinicheJens Overgaard
Published in: Acta oncologica (Stockholm, Sweden) (2019)
Keyphrases
  • clinical trial
  • circulating tumor
  • cell free
  • single cell
  • single molecule
  • cancer therapy
  • free survival
  • phase ii
  • open label
  • phase iii
  • double blind